Risk Assessment and Incidence of Vein Infusion Phlebitis After Intravenous Infusion of Proton Pump Inhibitors
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Occurence of infusion phlebitis
研究概览
简要总结
Intermittent or continuous proton pump inhibitor (PPI) therapy are recommended for high-risk bleeding ulcers according to the French Society of Gastroenterology. The prevalence of incidence of vein infusion phlebitis after PPI intravenous infusion is high in geriatric acute ward (about 10% of severe vein infusion phlebitis).
The primary of objective of the study is to determinate the prevalence of vein infusion phlebitis after PPI intravenous infusion in aging people.
The secondary of objective of the study if to determinate the factors of risk of vein infusion phlebitis.
详细描述
This is a multicenter observational study. 5 centers will participate to the study. Aging patients undergoing PPI intravenous infusion therapy will be proposed to be enrolled in the study. Paramedical observation will be performed during 5 days for each enrolled patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged > 70 years;
- •Undergo intravenous continuous or intermittent proton pump inhibitor therapy;
- •Patients being informed and not opposed to the study.
排除标准
- •Existing vein infusion phlebitis before the PPI infusion by intravenous route;
- •Under guardianship or curators;
- •Covered by french AME health system.
结局指标
主要结局
Occurence of infusion phlebitis
时间窗: at day-5
The Visual Infusion Phlebitis Scale will be used to define.
次要结局
- Factors of risk of vein infusion phlebitis(Throughout of the study, an average of 1 year)